Physician profile
Gregory Albert
NPI 1871669069
$45,897.29
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,600 · 2021: $19K · 2022: $624 · 2023: $2,037 · 2024: $485 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,905 · Education: $57.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,904.65 |
| Education | $57.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $29,402.21 | 2019-2025 | |
| Allergan, INC. | $12,288.69 | 2019-2022 | |
| Lumenis Be INC | $1,629.54 | 2023 | M22 |
| Abbvie INC. | $681.48 | 2023-2025 | Botox |
| Sientra, INC. | $460.02 | 2020-2022 | |
| Tela Bio, INC. | $436.58 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merz North America, INC. | $373.88 | 2019-2020 | |
| Davol INC. | $165.61 | 2021-2022 | |
| Galderma Laboratories, L.P. | $118.79 | 2019-2025 | Dysport |
| Medtronic, INC. | $60.53 | 2021-2022 | |
| Integra Lifesciences Corporation | $58.74 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Kowa Pharmaceuticals America, INC. | $58.46 | 2023 | Seglentis |
| Becton, Dickinson and Company | $34.37 | 2022 | |
| Apyx Medical Corporation | $31.36 | 2019 | |
| Vertical Pharmaceuticals, LLC | $28.69 | 2023 | Dsuvia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.91 | 2025 | |
| Coopersurgical, INC. | $18.78 | 2021 | |
| Kci USA, INC. | $15.79 | 2023 | Prevena Restor Bellaform |
| Pacira Pharmaceuticals Incorporated | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.